{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:13:48Z","timestamp":1761178428319,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.canrad.2012.10.011","type":"journal-article","created":{"date-parts":[[2012,12,25]],"date-time":"2012-12-25T02:30:12Z","timestamp":1356402612000},"page":"10-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["\u00c9volution des cancers de l\u2019\u0153sophage\u00a0: impact de la strat\u00e9gie th\u00e9rapeutique"],"prefix":"10.1016","volume":"17","author":[{"given":"D.","family":"Rousseau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Capitain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Denis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Girault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.-L.","family":"Poirier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Paumier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Cellier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Hamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.-A.","family":"Mah\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Mesgouez-Nebout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2012.10.011_bib0005","first-page":"1","article-title":"Epidemiology of esophageal cancer","volume":"155","author":"Pera","year":"2000"},{"key":"10.1016\/j.canrad.2012.10.011_bib0010","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1200\/JCO.2001.19.7.1970","article-title":"Esophageal cancer: the mode of lymphatic tumor cell spread and its prognostic significance","volume":"19","author":"Hosch","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2012.10.011_bib0015","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ejca.2006.07.021","article-title":"Survival of cancer patients in France: a population-based study from The Association of the French Cancer Registries (FRANCIM)","volume":"43","author":"Bossard","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.canrad.2012.10.011_bib0020","unstructured":"Th\u00e9saurus national de canc\u00e9rologie digestive\u00a0: cancer de l\u2019\u0153sophage (travail collaboratif sous \u00e9gide de la F\u00e9d\u00e9ration francophone de canc\u00e9rologie digestive [FFCD], de la F\u00e9d\u00e9ration nationale des centres de lutte contre le cancer [Unicancer], du Groupe coop\u00e9rateur multidisciplinaire en oncologie [Gercor], de la Soci\u00e9t\u00e9 fran\u00e7aise de chirurgie digestive [SFCD], de la Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique [SFRO] et de la Soci\u00e9t\u00e9 nationale fran\u00e7aise de gastroent\u00e9rologie [SNFGE]). Paris\u00a0: SNGE\u00a0; 2007. Disponible \u00e0 l\u2019adresse\u00a0: http:\/\/www.tncd.org\/ (acc\u00e8s le 20\/11\/2012)."},{"key":"10.1016\/j.canrad.2012.10.011_bib0025","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1056\/NEJM199206113262403","article-title":"Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus","volume":"326","author":"Herskovic","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2012.10.011_bib0030","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","article-title":"Preoperative chemoradiotherapy for esophageal or junctional cancer","volume":"366","author":"van Hagen","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2012.10.011_bib0035","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S1470-2045(11)70142-5","article-title":"Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis","volume":"12","author":"Sjoquist","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2012.10.011_bib0040","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1200\/JCO.2005.04.7118","article-title":"Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102","volume":"25","author":"Bedenne","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2012.10.011_bib0045","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1200\/JCO.2005.00.034","article-title":"Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus","volume":"23","author":"Stahl","year":"2005","journal-title":"J Clin Oncol"},{"year":"2002","series-title":"TNM classification of malignant tumours","author":"International Union against Cancer","key":"10.1016\/j.canrad.2012.10.011_bib0050"},{"key":"10.1016\/j.canrad.2012.10.011_bib0055","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa055531","article-title":"Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer","volume":"355","author":"Cunningham","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2012.10.011_bib0060","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1200\/JCO.2010.33.0597","article-title":"Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial","volume":"29","author":"Ychou","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2012.10.011_bib0065","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1097\/SLA.0b013e31824beb95","article-title":"Should Adenocarcinoma of the Esophagogastric junction be classified as esophageal cancer? A Comparative Analysis According to the Seventh AJCC TNM Classification","volume":"255","author":"Suh","year":"2012","journal-title":"Ann Surg"},{"key":"10.1016\/j.canrad.2012.10.011_bib0070","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1002\/cncr.26586","article-title":"Failure patterns in patients with esophageal cancer treated with definitive chemoradiation","volume":"118","author":"Welsh","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2012.10.011_bib0075","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ijrobp.2004.06.022","article-title":"Dose-response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapy","volume":"61","author":"Zhang","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2012.10.011_bib0080","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0360-3016(89)90324-6","article-title":"Ten-year follow-up of esophageal cancer treated by radical radiation therapy: analysis of 869\u00a0patients","volume":"16","author":"Sun","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2012.10.011_bib0085","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/jso.21312","article-title":"Impact of the number of resected and involved lymph nodes on esophageal cancer survival","volume":"100","author":"Chen","year":"2009","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.canrad.2012.10.011_bib0090","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1200\/JCO.2002.20.5.1167","article-title":"INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy","volume":"20","author":"Minsky","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2012.10.011_bib0095","first-page":"270a","article-title":"Definitve concurrent chemoradiation therapy in squamous cell oesophageal cancer: results of a french randomized trial comparing standard versus split-course irradiation (FNCLCC-FFCD 9305)","volume":"18","author":"Jacob","year":"1999","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.canrad.2012.10.011_bib0100","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.canrad.2012.08.003","article-title":"La radioth\u00e9rapie avec modulation d\u2019intensit\u00e9 rotationnelle apporte-t-elle un avantage dosim\u00e9trique dans le traitement du cancer bronchique lovalement \u00e9volu\u00e9\u00a0?","volume":"16","author":"Rousseau","year":"2012","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2012.10.011_bib0105","doi-asserted-by":"crossref","first-page":"e593","DOI":"10.1016\/j.ijrobp.2011.04.032","article-title":"Retrospective analysis of outcome differences in preoperative concurrent chemoradiation with or without elective nodal irradiation for esophageal squamous cell carcinoma","volume":"81","author":"Hsu","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2012.10.011_bib0110","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.radonc.2008.09.025","article-title":"Elective nodal irradiation (ENI) in definitive chemoradiotherapy (CRT) for squamous cell carcinoma of the thoracic esophagus","volume":"92","author":"Onozawa","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2012.10.011_bib0115","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.radonc.2010.10.021","article-title":"Details of recurrence sites after elective nodal irradiation (ENI) using 3D-conformal radiotherapy (3D-CRT) combined with chemotherapy for thoracic esophageal squamous cell carcinoma \u2013 a retrospective analysis","volume":"98","author":"Yamashita","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2012.10.011_bib0120","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ijrobp.2009.02.078","article-title":"Three-dimensional conformal radiation therapy for esophageal squamous cell carcinoma: is elective nodal irradiation necessary?","volume":"76","author":"Zhao","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2012.10.011_bib0125","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.ijrobp.2008.04.062","article-title":"Study to determine adequate margins in radiotherapy planning for esophageal carcinoma by detailing patterns of recurrence after definitive chemoradiotherapy","volume":"73","author":"Button","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2012.10.011_bib0130","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.canrad.2012.02.001","article-title":"TEP\/TDM en radioth\u00e9rapie: indications et perspectives","volume":"16","author":"Rossier","year":"2012","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2012.10.011_bib0135","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.ijrobp.2009.02.032","article-title":"Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy","volume":"76","author":"Liao","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2012.10.011_bib0140","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.canrad.2005.04.001","article-title":"Tomographie par \u00e9mission de positons et fusion d\u2019images de simulation virtuelle par tomodensitom\u00e9trie. Impact sur la planification de la radioth\u00e9rapie conformationnelle des cancers de l\u2019\u0153sophage","volume":"9","author":"Moureau-Zabotto","year":"2005","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2012.10.011_bib0145","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/j.1572-0241.1999.985_h.x","article-title":"Endoscopic ultrasound cannot determine suitability for esophagectomy after aggressive chemoradiotherapy for esophageal cancer","volume":"94","author":"Zuccaro","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.canrad.2012.10.011_bib0150","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ijrobp.2007.03.053","article-title":"Correlation of molecular response as measured by 18-FDG positron emission tomography with outcome after chemoradiotherapy in patients with esophageal carcinoma","volume":"69","author":"Konski","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2012.10.011_bib0155","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/cncr.20585","article-title":"2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma","volume":"101","author":"Swisher","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2012.10.011_bib0160","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.athoracsur.2004.04.046","article-title":"Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer","volume":"78","author":"Swisher","year":"2004","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.canrad.2012.10.011_bib0165","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1007\/s00330-012-2459-5","article-title":"Metabolic response at repeat PET\/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer","volume":"22","author":"Gillies","year":"2012","journal-title":"Eur Radiol"},{"key":"10.1016\/j.canrad.2012.10.011_bib0170","doi-asserted-by":"crossref","first-page":"872","DOI":"10.2967\/jnumed.111.098699","article-title":"Evaluation of response to neoadjuvant chemotherapy for esophageal cancer: PET response criteria in solid tumors versus response evaluation criteria in solid tumors","volume":"53","author":"Yanagawa","year":"2012","journal-title":"J Nucl Med"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321812004179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321812004179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:20:34Z","timestamp":1761135634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321812004179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S1278321812004179"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2012.10.011","relation":{},"ISSN":["1278-3218"],"issn-type":[{"type":"print","value":"1278-3218"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u00c9volution des cancers de l\u2019\u0153sophage\u00a0: impact de la strat\u00e9gie th\u00e9rapeutique","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2012.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}